Reassessment of Alzheimer's Drug Raises Hope--and Concerns
Friday, December 6, 2019 - 15:30
in Health & Medicine
Will the benefits of aducanumab be enough to justify FDA approval, given its small benefit and high price? -- Read more on ScientificAmerican.com